Unraveling 50-yearold clues linking neurodegeneration and cancer to cycad toxins: Are microRNAs common mediators?

Peter Spencer, Rebecca C. Fry, Glen E. Kisby

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Recognition of overlapping molecular signaling activated by a chemical trigger of cancer and neurodegeneration is new, but the path to this discovery has been long and potholed. Six conferences (1962-1972) examined the puzzling neurotoxic and carcinogenic properties of a then-novel toxin [cycasin: methylazoxymethanol (MAM)-β-D-glucoside] in cycad plants used traditionally for food and medicine on Guam where a complex neurodegener-ative disease plagued the indigenous population. Affected families showed combinations of amyotrophic lateral sclerosis (ALS), parkinsonism (P), and/or a dementia (D) akin to Alzheimer's disease (AD). Modernization saw declining disease rates on Guam and remarkable changes in clinical phenotype (ALS was replaced by P-D and then by D) and in two genetically distinct ALS-PDC-affected populations (Kii-Japan, West Papua-Indonesia) that used cycad seed medicinally. MAM forms DNA lesions-repaired by O6-methylguanine methyltransferase (MGMT)-that perturb mouse brain development and induce malignant tumors in peripheral organs. The brains of young adult MGMT-deficient mice given a single dose of MAM show DNA lesion-linked changes in cell-signaling pathways associated with miRNA-1, which is implicated in colon, liver, and prostate cancers, and in neurological disease, notably AD. MAM is metabolized to formaldehyde, a human carcinogen. Formaldehyde-responsive miRNAs predicted to modulate MAM-associated genes in the brains of MGMT-deficient mice include miR-17-5p and miR-18d, which regulate genes involved in tumor suppression, DNA repair, amyloid deposition, and neurotransmission. These findings marry cycad-associated ALS-PDC with colon, liver, and prostate cancer; they also add to evidence linking changes in microRNA status both to ALS, AD, and parkinsonism, and to cancer initiation and progression.

Original languageEnglish (US)
Article numberArticle 192
JournalFrontiers in Genetics
Volume3
Issue numberSEP
DOIs
StatePublished - 2012

Fingerprint

Amyotrophic Lateral Sclerosis
MicroRNAs
Methyltransferases
Guam
Alzheimer Disease
Parkinsonian Disorders
Neoplasms
Liver Neoplasms
Colonic Neoplasms
Formaldehyde
Cycasin
Prostatic Neoplasms
Brain
Indonesia
DNA
Glucosides
Social Change
Population Groups
Amyloid
Synaptic Transmission

Keywords

  • ALS-PDC
  • Alzheimer disease
  • Amyotrophic lateral sclerosis
  • BMAA
  • Colon cancer
  • DNA damage
  • Formaldehyde
  • Methylazoxymethanol

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Cite this

Unraveling 50-yearold clues linking neurodegeneration and cancer to cycad toxins : Are microRNAs common mediators? / Spencer, Peter; Fry, Rebecca C.; Kisby, Glen E.

In: Frontiers in Genetics, Vol. 3, No. SEP, Article 192, 2012.

Research output: Contribution to journalArticle

@article{6fcb60ab3a6744c88341deb251114df5,
title = "Unraveling 50-yearold clues linking neurodegeneration and cancer to cycad toxins: Are microRNAs common mediators?",
abstract = "Recognition of overlapping molecular signaling activated by a chemical trigger of cancer and neurodegeneration is new, but the path to this discovery has been long and potholed. Six conferences (1962-1972) examined the puzzling neurotoxic and carcinogenic properties of a then-novel toxin [cycasin: methylazoxymethanol (MAM)-β-D-glucoside] in cycad plants used traditionally for food and medicine on Guam where a complex neurodegener-ative disease plagued the indigenous population. Affected families showed combinations of amyotrophic lateral sclerosis (ALS), parkinsonism (P), and/or a dementia (D) akin to Alzheimer's disease (AD). Modernization saw declining disease rates on Guam and remarkable changes in clinical phenotype (ALS was replaced by P-D and then by D) and in two genetically distinct ALS-PDC-affected populations (Kii-Japan, West Papua-Indonesia) that used cycad seed medicinally. MAM forms DNA lesions-repaired by O6-methylguanine methyltransferase (MGMT)-that perturb mouse brain development and induce malignant tumors in peripheral organs. The brains of young adult MGMT-deficient mice given a single dose of MAM show DNA lesion-linked changes in cell-signaling pathways associated with miRNA-1, which is implicated in colon, liver, and prostate cancers, and in neurological disease, notably AD. MAM is metabolized to formaldehyde, a human carcinogen. Formaldehyde-responsive miRNAs predicted to modulate MAM-associated genes in the brains of MGMT-deficient mice include miR-17-5p and miR-18d, which regulate genes involved in tumor suppression, DNA repair, amyloid deposition, and neurotransmission. These findings marry cycad-associated ALS-PDC with colon, liver, and prostate cancer; they also add to evidence linking changes in microRNA status both to ALS, AD, and parkinsonism, and to cancer initiation and progression.",
keywords = "ALS-PDC, Alzheimer disease, Amyotrophic lateral sclerosis, BMAA, Colon cancer, DNA damage, Formaldehyde, Methylazoxymethanol",
author = "Peter Spencer and Fry, {Rebecca C.} and Kisby, {Glen E.}",
year = "2012",
doi = "10.3389/fgene.2012.00192",
language = "English (US)",
volume = "3",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Unraveling 50-yearold clues linking neurodegeneration and cancer to cycad toxins

T2 - Are microRNAs common mediators?

AU - Spencer, Peter

AU - Fry, Rebecca C.

AU - Kisby, Glen E.

PY - 2012

Y1 - 2012

N2 - Recognition of overlapping molecular signaling activated by a chemical trigger of cancer and neurodegeneration is new, but the path to this discovery has been long and potholed. Six conferences (1962-1972) examined the puzzling neurotoxic and carcinogenic properties of a then-novel toxin [cycasin: methylazoxymethanol (MAM)-β-D-glucoside] in cycad plants used traditionally for food and medicine on Guam where a complex neurodegener-ative disease plagued the indigenous population. Affected families showed combinations of amyotrophic lateral sclerosis (ALS), parkinsonism (P), and/or a dementia (D) akin to Alzheimer's disease (AD). Modernization saw declining disease rates on Guam and remarkable changes in clinical phenotype (ALS was replaced by P-D and then by D) and in two genetically distinct ALS-PDC-affected populations (Kii-Japan, West Papua-Indonesia) that used cycad seed medicinally. MAM forms DNA lesions-repaired by O6-methylguanine methyltransferase (MGMT)-that perturb mouse brain development and induce malignant tumors in peripheral organs. The brains of young adult MGMT-deficient mice given a single dose of MAM show DNA lesion-linked changes in cell-signaling pathways associated with miRNA-1, which is implicated in colon, liver, and prostate cancers, and in neurological disease, notably AD. MAM is metabolized to formaldehyde, a human carcinogen. Formaldehyde-responsive miRNAs predicted to modulate MAM-associated genes in the brains of MGMT-deficient mice include miR-17-5p and miR-18d, which regulate genes involved in tumor suppression, DNA repair, amyloid deposition, and neurotransmission. These findings marry cycad-associated ALS-PDC with colon, liver, and prostate cancer; they also add to evidence linking changes in microRNA status both to ALS, AD, and parkinsonism, and to cancer initiation and progression.

AB - Recognition of overlapping molecular signaling activated by a chemical trigger of cancer and neurodegeneration is new, but the path to this discovery has been long and potholed. Six conferences (1962-1972) examined the puzzling neurotoxic and carcinogenic properties of a then-novel toxin [cycasin: methylazoxymethanol (MAM)-β-D-glucoside] in cycad plants used traditionally for food and medicine on Guam where a complex neurodegener-ative disease plagued the indigenous population. Affected families showed combinations of amyotrophic lateral sclerosis (ALS), parkinsonism (P), and/or a dementia (D) akin to Alzheimer's disease (AD). Modernization saw declining disease rates on Guam and remarkable changes in clinical phenotype (ALS was replaced by P-D and then by D) and in two genetically distinct ALS-PDC-affected populations (Kii-Japan, West Papua-Indonesia) that used cycad seed medicinally. MAM forms DNA lesions-repaired by O6-methylguanine methyltransferase (MGMT)-that perturb mouse brain development and induce malignant tumors in peripheral organs. The brains of young adult MGMT-deficient mice given a single dose of MAM show DNA lesion-linked changes in cell-signaling pathways associated with miRNA-1, which is implicated in colon, liver, and prostate cancers, and in neurological disease, notably AD. MAM is metabolized to formaldehyde, a human carcinogen. Formaldehyde-responsive miRNAs predicted to modulate MAM-associated genes in the brains of MGMT-deficient mice include miR-17-5p and miR-18d, which regulate genes involved in tumor suppression, DNA repair, amyloid deposition, and neurotransmission. These findings marry cycad-associated ALS-PDC with colon, liver, and prostate cancer; they also add to evidence linking changes in microRNA status both to ALS, AD, and parkinsonism, and to cancer initiation and progression.

KW - ALS-PDC

KW - Alzheimer disease

KW - Amyotrophic lateral sclerosis

KW - BMAA

KW - Colon cancer

KW - DNA damage

KW - Formaldehyde

KW - Methylazoxymethanol

UR - http://www.scopus.com/inward/record.url?scp=84874579683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874579683&partnerID=8YFLogxK

U2 - 10.3389/fgene.2012.00192

DO - 10.3389/fgene.2012.00192

M3 - Article

C2 - 23060898

AN - SCOPUS:84874579683

VL - 3

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - SEP

M1 - Article 192

ER -